SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-20-000108
Filing Date
2020-07-06
Accepted
2020-07-06 06:43:38
Documents
18
Period of Report
2020-07-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-2020x07x02x2020jnj.htm   iXBRL 8-K 45275
2 EXHIBIT 99 a070620emergentandjansse.htm EX-99 10374
8 a070620emergentandjansse001.jpg GRAPHIC 258427
9 a070620emergentandjansse002.jpg GRAPHIC 270767
10 a070620emergentandjansse003.jpg GRAPHIC 143296
  Complete submission text file 0001367644-20-000108.txt   1134962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20200702.xsd EX-101.SCH 4492
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20200702_cal.xml EX-101.CAL 662
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20200702_def.xml EX-101.DEF 1512
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20200702_lab.xml EX-101.LAB 27268
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20200702_pre.xml EX-101.PRE 14152
11 EXTRACTED XBRL INSTANCE DOCUMENT ebs-2020x07x02x2020jnj_htm.xml XML 4414
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 201012126
SIC: 2834 Pharmaceutical Preparations